Illumina | ILMN - Gross Profit On Sales



Illumina reported $695M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Agilent USD 888M 22M Jul/2025
Bio Techne USD 198.81M 15.74M Jun/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Boston Scientific USD 3.42B 228M Jun/2025
Bruker USD 357.9M 33.3M Jun/2025
Charles River Laboratories USD 291.68M 48.42M Jun/2025
Danaher USD 3.52B 3M Jun/2025
Dentsply International USD 490M 24M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Exact Sciences USD 562.45M 61.91M Jun/2025
Hologic USD 576.6M 15.9M Jun/2025
Illumina USD 695M 12M Jun/2025
Intuitive Surgical USD 1.62B 160.2M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Laboratory Of America USD 1.05B 98.2M Jun/2025
Mettler Toledo International USD 579.88M 54M Jun/2025
Myriad Genetics USD 134.2M 16.7M Mar/2025
Quest Diagnostics USD 904M 35M Jun/2025
Quidel USD 227M 116.3M Jun/2025
Repligen USD 91.14M 385K Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Standard Biotools USD 10.63M 11.28M Jun/2025
Thermo Fisher Scientific USD 4.05B 260M Jun/2025
Waters USD 438.02M 53.06M Jun/2025